mezlocillin has been researched along with cefotetan in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fratoni, A; Mancuso, S; Oliva, GC; Papadia, L; Paparella, PL; Pieroni, A | 1 |
| Billings, P; Cooper, M; Leaper, D; Turner, A | 1 |
| Bassler, M; Becker, C; Daschner, FD; Just, HM | 1 |
| Alegente, G; Castelli, A; De Lalla, F; De Nunno, T; Savio, S | 1 |
| Bonifacino, G; Bucciero, A; Conturso, R; De Lalla, F; Lovotti, M; Molteni, E; Ognissanti, F; Tagliabue, R | 1 |
| Alegente, G; Bucciero, A; Conturso, R; De Lalla, F; Marcolli, R; Molteni, E; Regallo, M; Tagliabue, R | 1 |
2 trial(s) available for mezlocillin and cefotetan
| Article | Year |
|---|---|
Antibiotic prophylaxis in gynecological surgery.
Topics: Adult; Aged; Bacterial Infections; Cefotetan; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Injections, Intravenous; Mezlocillin; Middle Aged; Prospective Studies | 1990 |
Intraoperative microbiological sampling is unhelpful after prophylactic antibiotic.
Topics: Bacteria; Bacterial Infections; Cefazolin; Cefotetan; Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Mezlocillin; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1987 |
7 other study(ies) available for mezlocillin and cefotetan
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
In vitro combination effects of cefotetan with four aminoglycosides, piperacillin and mezlocillin on gram-positive and gram-negative nosocomial bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotetan; Cephamycins; Cross Infection; Drug Interactions; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mezlocillin; Microbial Sensitivity Tests; Piperacillin | 1984 |
Antibiotic prophylaxis in high-risk biliary tract surgery: a comparison of mezlocillin and cefotetan. Preliminary results.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biliary Tract Surgical Procedures; Cefotetan; Clinical Trials as Topic; Female; Humans; Male; Mezlocillin; Middle Aged; Risk Factors; Sepsis; Surgical Wound Infection | 1989 |
A comparison of mezlocillin and cefotetan in cesarean section prophylaxis: a prospective, randomized study. Preliminary results.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefotetan; Cesarean Section; Female; Humans; Mezlocillin; Pregnancy; Randomized Controlled Trials as Topic; Risk Factors; Surgical Wound Infection; Treatment Outcome | 1989 |
Mezlocillin versus cefotetan in abdominal hysterectomy prophylaxis: a prospective randomized study. Preliminary results.
Topics: Antibiotic Prophylaxis; Bacterial Infections; Cefotetan; Female; Humans; Hysterectomy; Mezlocillin; Middle Aged; Randomized Controlled Trials as Topic; Surgical Wound Infection; Treatment Outcome | 1989 |